cerrar
Tagged with Opinion

The Ideal Pharma Country Manager: China (Ardent Search)
The lowdown on what it takes to be a country manager of a multinational pharma company in some of the world’s most challenging markets. Robert Hall…

The Future of Pharma Sales Training
For PharmaBoardroom, Ian Chamberlain has already covered the changing role of the medical rep and the line manager of tomorrow. This time he turns…

Rare Diseases in South Africa: Bridging the Gap for Inclusive…
Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a registered NPO born out of necessity when her oldest child was diagnosed with…

“Why We Need Public-Private Partnerships in Drug…
Pierre Meulien, Executive Director of the Innovative Medicines Initiative (IMI) in Europe, outlines the value of public-private partnerships in drug…

“Canada Needs to do Better in Supporting Innovative…
Brian Hilberdink, President of Novo Nordisk Canada, calls for the Canadian government to encourage and invest in innovative biopharmaceutical…

Success in Rare Disease Patient Advocacy — What it Takes
After her son was diagnosed with SYNGAP1 – an extremely rare gene mutation – Monica Weldon founded Bridge the Gap – SYNGAP Education and…

The Ideal Pharma Country Manager: South Korea (DHR International)
Looking at what it takes to be a country manager of a multinational pharma company in some of the world’s most challenging markets. DHR…

“Watch Out! Unsophisticated AI in Healthcare Can Perpetuate…
As the healthcare industry continues to hype about AI's potential to be transformative, it is important to remember that even software can harbour a…

India’s Drug Regulatory Reforms: Building Trust
Dilip Shah, the Secretary-General of the Indian Pharmaceutical Alliance advocates for a stronger and more empowered regulator in India if the country…

Mexico’s Healthcare System: Perspectives from the Pharma…
Cristobal Thompson is the Executive Director at AMIIF (Asociacion Mexicana de Industrias de Investigacion Farmaceutica). The AMIIF represents more…

Megatrends from the 2019 Deloitte Life Sciences Outlook
Deloitte's Global Life Sciences & Health Care industry leader, Greg Reh gives us an exclusive insight into their forecast for 2019's industry…

Investing in Canadian Health: We Know the Cost, but Can We Talk…
As the President of Innovative Medicines Canada, Pamela Fralick leads the industry association for Canada’s innovative pharmaceutical companies,…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here